다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Trillium Therapeutics Inc (TRIL)
Trillium Therapeutics Inc (TRIL) 뉴스

TRIL

Trillium Therapeutics (TRIL)

Trillium Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TRIL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2021/11/22	20:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	05:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	03:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	03:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	03:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	03:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	03:28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	03:28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	03:27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	03:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	03:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/20	03:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/19	20:44	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/18	06:02	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/18	06:02	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/18	06:02	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/18	06:01	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/18	06:01	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/17	23:28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/17	23:24	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/17	07:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/16	07:07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/11/12	21:01	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/10/29	19:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/10/29	06:00	GlobeNewswire Inc.	Trillium Therapeutics Receives Final Court Order Approving Arrangement	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/10/27	19:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/10/27	06:15	GlobeNewswire Inc.	Trillium Securityholders Approve Acquisition by Pfizer	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/10/20	19:05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/10/20	19:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TRIL	Trillium Therapeutics Inc
2021/10/15	19:34	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:TRIL	Trillium Therapeutics Inc

검색 관련기사 보기:NASDAQ:TRIL

1 2 3 4 5 6 7 8 9 10 다음 >>

MSC Industrial Direct

Threshold Network Token

Air Transport Services

Intesa Sanpaolo

Medlab Clinical (PK)

Kyber Network Crystal v2

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관